Wankhabe N. et al. fused ML (SVM, RF, NBC) and DL (multi-task deep neural network—MTDNN) models to investigate new inhibitors against dipeptidyl peptidase-4 (DPP-4), a significant enzyme in diabetes pathophysiology. Here, DPP4 is linked to diabetes mellitus.